Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 329634, 11 pages
http://dx.doi.org/10.1155/2014/329634
Research Article

Experimental Gestational Diabetes Mellitus Induces Blunted Vasoconstriction and Functional Changes in the Rat Aorta

1Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón, Colonia Santo Tomás, 11340 DF, Mexico
2Unidad de Biomedicina, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Avenida De los Barrios 1, Los Reyes Iztacala, 54090 Tlalnepantla, Mexico

Received 21 October 2014; Accepted 17 December 2014; Published 28 December 2014

Academic Editor: John J. Gildea

Copyright © 2014 Cecilia Tufiño et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. L. Setji, A. J. Brown, and M. N. Feinglos, “Gestational diabetes mellitus,” Clinical Diabetes, vol. 23, no. 1, pp. 17–24, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. L. A. Barbour, “Changing perspectives in pre-existing diabetes and obesity in pregnancy: maternal and infant short-and long-term outcomes,” Current Opinion in Endocrinology & Diabetes and Obesity, vol. 21, no. 4, pp. 257–263, 2014. View at Publisher · View at Google Scholar
  3. American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 36, supplement 1, pp. S67–S74, 2013. View at Publisher · View at Google Scholar
  4. M. I. Schmidt, B. B. Duncan, A. J. Reichelt et al., “Gestational diabetes mellitus diagnosed with a 2-h 75-g oral glucose tolerance test and adverse pregnancy outcomes,” Diabetes Care, vol. 24, no. 7, pp. 1151–1155, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. B. R. Shah, R. Retnakaran, and G. L. Booth, “Increased risk of cardiovascular disease in young women following gestational diabetes mellitus,” Diabetes Care, vol. 31, no. 8, pp. 1668–1669, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. K. E. Wellen and G. S. Hotamisligil, “Obesity-induced inflammatory changes in adipose tissue,” The Journal of Clinical Investigation, vol. 112, no. 12, pp. 1785–1788, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. M. A. R. Torres, “Diabetes mellitus gestacional. Experiencia en una institución de tercer nivel de atención,” Ginecología y Obstetricia de México, vol. 73, pp. 484–491, 2005. View at Google Scholar
  8. H. Keita, E. Ramírez-San Juan, N. Paniagua-Castro, L. Garduño-Siciliano, and L. Quevedo, “The long-term ingestion of a diet high in extra virgin olive oil produces obesity and insulin resistance but protects endothelial function in rats: a preliminary study,” Diabetology & Metabolic Syndrome, vol. 5, no. 1, article 53, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Jerez, L. Sierra, A. Coviello, and M. P. de Bruno, “Endothelial dysfunction and improvement of the angiotensin II-reactivity in hypercholesterolemic rabbits: role of cyclooxygenase metabolites,” European Journal of Pharmacology, vol. 580, no. 1-2, pp. 182–189, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. L. T. Tran, V. G. Yuen, and J. H. McNeill, “The fructose-fed rat: a review on the mechanisms of fructose-induced insulin resistance and hypertension,” Molecular and Cellular Biochemistry, vol. 332, no. 1-2, pp. 145–159, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. L. T. Tran, K. M. MacLeod, and J. H. McNeill, “Endothelin-1 modulates angiotensin II in the development of hypertension in fructose-fed rats,” Molecular and Cellular Biochemistry, vol. 325, no. 1-2, pp. 89–97, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Galipeau, S. Verma, and J. H. McNeill, “Female rats are protected against fructose-induced changes in metabolism and blood pressure,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 283, no. 6, pp. H2478–H2484, 2002. View at Google Scholar · View at Scopus
  13. K. Holemans, S. Caluwaerts, L. Poston, and F. A. van Assche, “Diet-induced obesity in the rat: a model for gestational diabetes mellitus,” American Journal of Obstetrics & Gynecology, vol. 190, no. 3, pp. 858–865, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. U. Stroth and T. Unger, “The renin-angiotensin system and its receptors,” Journal of Cardiovascular Pharmacology, vol. 33, no. 1, pp. S21–S28, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Raffai, G. Khang, and P. M. Vanhoutte, “Angiotensin-(1–7) augments endothelium-dependent relaxations of porcine coronary arteries to bradykinin by inhibiting angiotensin-converting enzyme 1,” Journal of Cardiovascular Pharmacology, vol. 63, no. 5, pp. 453–460, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. M. D. Nyby, K. Abedi, V. Smutko, P. Eslami, and M. L. Tuck, “Vascular angiotensin type 1 receptor expression is associated with vascular dysfunction, oxidative stress and inflammation in fructose-fed rats,” Hypertension Research, vol. 30, no. 5, pp. 451–457, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Yayama and H. Okamoto, “Angiotensin II-induced vasodilation via type 2 receptor: role of bradykinin and nitric oxide,” International Immunopharmacology, vol. 8, no. 2, pp. 312–318, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Härdtner, C. Mörke, R. Walther, C. Wolke, and U. Lendeckel, “High glucose activates the alternative ACE2/Ang-(1–7)/Mas and APN/Ang IV/IRAP RAS axes in pancreatic β-cells,” International Journal of Molecular Medicine, vol. 32, no. 4, pp. 795–804, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Pernomian, M. S. Gomes, C. B. A. Restini, A. S. Pupo, and A. M. de Oliveira, “Cross-talk with β2-adrenoceptors enhances ligand affinity properties from endothelial alpha1D-adrenoceptors that mediates carotid relaxation,” Journal of Pharmacy and Pharmacology, vol. 65, no. 9, pp. 1337–1346, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. K. H. S. Arun, C. L. Kaul, and R. Poduri, “Tempol augments angiotensin II-induced AT2 receptor-mediated relaxation in diabetic rat thoracic aorta,” Journal of Hypertension, vol. 22, no. 11, pp. 2143–2152, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Jerez, P. D. B. María, and C. Alfredo, “Cross talk between angiotensin II and alpha 1 adrenergic receptors in rabbit aorta: role of endothelium,” Journal of Cardiovascular Pharmacology, vol. 43, no. 3, pp. 402–409, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Kleinwechter, U. Schäfer-Graf, C. Bührer et al., “Gestational diabetes mellitus (GDM) diagnosis, therapy and follow-up care,” Experimental and Clinical Endocrinology &Diabetes, vol. 122, no. 7, pp. 395–405, 2014. View at Publisher · View at Google Scholar
  23. S. N. Iyer and M. J. Katovich, “Effect of acute and chronic losartan treatment on glucose tolerance and insulin sensitivity in fructose-fed rats,” American Journal of Hypertension, vol. 9, no. 7, pp. 662–668, 1996. View at Publisher · View at Google Scholar · View at Scopus
  24. D. M. Galipeau, L. Yao, and J. H. McNeill, “Relationship among hyperinsulinemia, insulin resistance, and hypertension is dependent on sex,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 283, no. 2, pp. H562–H567, 2002. View at Google Scholar · View at Scopus
  25. J. R. Sowers, “Diabetes mellitus and vascular disease,” Hypertension, vol. 61, no. 5, pp. 943–947, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Barton, R. Carmona, J. Ortmann, J. E. Krieger, and T. Traupe, “Obesity-associated activation of angiotensin and endothelin in the cardiovascular system,” International Journal of Biochemistry and Cell Biology, vol. 35, no. 6, pp. 826–837, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Ghatta and P. Ramarao, “Increased contractile responses to 5-hydroxytryptamine and Angiotensin II in high fat diet fed rat thoracic aorta,” Lipids in Health and Disease, vol. 3, article 19, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Zhang, J. D. Knudson, S. Setty et al., “Coronary arteriolar vasoconstriction to angiotensin II is augmented in prediabetic metabolic syndrome via activation of AT1 receptors,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 288, no. 5, pp. H2154–H2162, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. I. Bhattacharya, A. L. Mundy, C. C. Widmer, M. Kretz, and M. Barton, “Regional heterogeneity of functional changes in conduit arteries after high-fat diet,” Obesity, vol. 16, no. 4, pp. 743–748, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. S. N. Iyer and M. J. Katovich, “Effect of chronic losartan potassium treatment on fructose-induced hypertension,” Life Sciences, vol. 55, no. 7, pp. PL139–PL144, 1994. View at Google Scholar · View at Scopus
  31. P.-S. Hsieh, Y.-H. Tai, C.-H. Loh, K.-C. Shih, W.-T. Cheng, and C.-H. Chu, “Functional interaction of AT1 and AT2 receptors in fructose-induced insulin resistance and hypertension in rats,” Metabolism, vol. 54, no. 2, pp. 157–164, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. G. D'Angelo, A. A. Elmarakby, D. M. Pollock, and D. W. Stepp, “Fructose feeding increases insulin resistance but not blood pressure in Sprague-Dawley rats,” Hypertension, vol. 46, no. 4, pp. 806–811, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. F. T. Spradley, K.-T. Kang, and J. S. Pollock, “Short-term hypercaloric diet induces blunted aortic vasoconstriction and enhanced vasorelaxation via increased nitric oxide synthase 3 activity and expression in Dahl salt-sensitive rats,” Acta Physiologica, vol. 207, no. 2, pp. 358–368, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. J. A. Velazquez-Roman, S. Villafaña, P. Lopez Sanchez, E. Fernandez-Vallín, and R. A. Bobadilla Lugo, “Effect of pregnancy and diabetes on vascular receptors for angiotensin II,” Clinical and Experimental Hypertension, vol. 33, no. 3, pp. 167–173, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. M. D. Savvidou, L. Geerts, and K. H. Nicolaides, “Impaired vascular reactivity in pregnant women with insulin-dependent diabetes mellitus,” American Journal of Obstetrics and Gynecology, vol. 186, no. 1, pp. 84–88, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Vasudevan, P. R. Nagareddy, and J. H. McNeill, “Gonadectomy prevents endothelial dysfunction in fructose-fed male rats, a factor contributing to the development of hypertension,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 291, no. 6, pp. H3058–H3064, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. M. R. Meyer, E. Haas, and M. Barton, “Gender differences of cardiovascular disease: new perspectives for estrogen receptor signaling,” Hypertension, vol. 47, no. 6, pp. 1019–1026, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. R. L. Santos, E. B. Marin, W. L. S. Gonçalves, N. S. Bissoli, G. R. Abreu, and M. R. Moysés, “Sex differences in the coronary vasodilation induced by 17 β-oestradiol in the isolated perfused heart from spontaneously hypertensive rats,” Acta Physiologica, vol. 200, no. 3, pp. 203–210, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. L. L. Yanes, J. C. Sartori-Valinotti, R. Iliescu et al., “Testosterone-dependent hypertension and upregulation of intrarenal angiotensinogen in Dahl salt-sensitive rats,” American Journal of Physiology—Renal Physiology, vol. 296, no. 4, pp. F771–F779, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Nasser, N. Clere, L. Botelle et al., “Opposite effects of angiotensins receptors type 2 and type 4 on streptozotocin induced diabetes vascular alterations in mice,” Cardiovascular Diabetology, vol. 13, no. 1, article 40, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. I. Dhar, A. Dhar, L. Wu, and K. M. Desai, “Increased methylglyoxal formation with upregulation of Renin Angiotensin system in fructose fed sprague dawley rats,” PLoS ONE, vol. 8, no. 9, Article ID e74212, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Shinozaki, K. Ayajiki, Y. Nishio, T. Sugaya, A. Kashiwagi, and T. Okamura, “Evidence for a causal role of the renin-angiotensin system in vascular dysfunction associated with insulin resistance,” Hypertension, vol. 43, no. 2, pp. 255–262, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Manrique, G. Lastra, and J. R. Sowers, “New insights into insulin action and resistance in the vasculature,” Annals of the New York Academy of Sciences, vol. 1311, no. 1, pp. 138–150, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. F. Cosentino, C. Savoia, P. de Paolis et al., “Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists,” American Journal of Hypertension, vol. 18, no. 4, pp. 493–499, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. M. S. Coelho, K. L. Lopes, R. D. A. Freitas et al., “High sucrose intake in rats is associated with increased ACE2 and angiotensin-(1–7) levels in the adipose tissue,” Regulatory Peptides, vol. 162, no. 1–3, pp. 61–67, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. R. A. Fraga-Silva, F. P. Costa-Fraga, T. M. Murça et al., “Angiotensin-converting enzyme 2 activation improves endothelial function,” Hypertension, vol. 61, no. 6, pp. 1233–1238, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. H. Suzuki, K. Eguchi, H. Ohtsu et al., “Activation of endothelial nitric oxide synthase by the angiotensin II type 1 receptor,” Endocrinology, vol. 147, no. 12, pp. 5914–5920, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. C. Zhang, T. W. Hein, W. Wang, and L. Kuo, “Divergent roles of angiotensin II AT1 and AT2 receptors in modulating coronary microvascular function,” Circulation Research, vol. 92, no. 3, pp. 322–329, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Krause, J. Rodrigues-Krause, C. O'Hagan et al., “Differential nitric oxide levels in the blood and skeletal muscle of type 2 diabetic subjects may be consequence of adiposity: a preliminary study,” Metabolism, vol. 61, no. 11, pp. 1528–1537, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Sánchez, C. Contreras, P. Martínez et al., “Enhanced cyclooxygenase 2-mediated vasorelaxation in coronary arteries from insulin-resistant obese Zucker rats,” Atherosclerosis, vol. 213, no. 2, pp. 392–399, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Félétou, Y. Huang, and P. M. Vanhoutte, “Endothelium-mediated control of vascular tone: COX-1 and COX-2 products,” British Journal of Pharmacology, vol. 164, no. 3, pp. 894–912, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. J. Jiang, L. Tran, H. Vasudevan, Z. Xia, V. G. Yuen, and J. H. McNeill, “Endothelin-1 blockade prevents COX2 induction and TXA2 production in the fructose hypertensive rat,” Canadian Journal of Physiology and Pharmacology, vol. 85, no. 3-4, pp. 422–429, 2007. View at Publisher · View at Google Scholar
  53. R. A. S. Santos and A. J. Ferreira, “Angiotensin-(1-7) and the renin-angiotensin system,” Current Opinion in Nephrology and Hypertension, vol. 16, no. 2, pp. 122–128, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. H. A. Peredo, M. A. Mayer, M. Rodríguez Fermepín, D. Grinspon, and A. M. Puyó, “Oral treatment and in vitro incubation with fructose modify vascular prostanoid production in the rat,” Autonomic and Autacoid Pharmacology, vol. 26, no. 1, pp. 15–20, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. M. R. Yadav, H. P. Gandhi, P. P. Naik, and R. Giridhar, “Revelation on the potency of α1-blockers parallel blockade of angiotensin II receptor: a new finding,” Pharmaceutical Biology, vol. 50, no. 4, pp. 439–442, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. L. L. Brunton, J. S. Lazo, and K. L. Parker, Goodman & Gilman Las Bases Farmacológicas de la Terapéutica, 12th edition, 2011.
  57. E. Cediel, N. de Las Heras, D. Sanz-Rosa, O. Velasco, V. Cachofeiro, and V. Lahera, “AT-1 receptor antagonism modifies the mediation of endothelin-1, thromboxane A2, and catecholamines in the renal constrictor response to angiotensin II,” Kidney International, vol. 67, pp. S3–S9, 2005. View at Google Scholar · View at Scopus
  58. J. Stupin and B. Arabin, “Overweight and obesity before, during and after pregnancy: part 1: pathophysiology, molecular biology and epigenetic consequences,” Geburtshilfe und Frauenheilkunde, vol. 74, no. 7, pp. 639–645, 2014. View at Publisher · View at Google Scholar